Toggle menu

3MG

Start date:
Historic
End date:
June 2012
Co-ordinated by:
University of Sheffield

A randomised trial of intravenous or nebulised magnesium sulphate versus placebo for acute severe asthma.

 

Aim

To assess the effectiveness of IV and nebulised magnesium sulphate in the treatment of acute severe asthma.

Trial Design

Multi centre randomised controlled trial of intravenous (IV) or nebulised magnesium sulphate versus placebo for acute severe asthma

Chief Investigator

Professor Steve Goodacre

Local PI

Professor Alasdair Gray

List of Publications – references

S Goodacre, J Cohen, M Bradburn, A Gray, J Benger, T Coats on behalf of the 3Mg Research Team. The 3Mg Trial: Randomised controlled trial of intravenous or nebulised magnesium sulphate or standard therapy for severe acute asthma. The Lancet Respiratory Medicine. (2013); 1:293 – 300.

Goodacre S, Cohen J, Bradburn M, Stevens J, Gray A, Benger J, et al. The 3Mg trial: a randomised controlled trial of intravenous or nebulised magnesium sulphate versus placebo in adults with acute severe asthma. . Health Technology Assessment. (2014);18(22).

Local PI

Professor Alasdair Gray

Director of EMERGE & Consultant in Emergency Medicine

More EMERGE Trials

Molecular and cellular analysis of intracranial tumours

Read more

BRAINED

Molecular and cellular analysis of intracranial tumours

Traumatic Brain Injury (TBI) is the leading cause of death and disabilities amongst young people worldwide. Many sufferers develop chronic physical and mental health problems and are unable to work or re-engage socially after their injuries. There are therefore significant health and socioeconomic consequences.

Read more

PitSTOP

A study examining the Prevalence and Risk of Anterior Pituitary Dysfunction following Traumatic Brain Injury

The Emergency Medicine Annotated Bioresource Consortium (EM-ABC): A pilot and feasability programme

Read more

EMERGE Biobank

Developing a bioresource for all emergency presentations